Acquisition by Lin Elizabeth Yeu of 4010 shares of STAAR Surgical at 40.11 subject to Rule 16b-3
STAA Stock | USD 26.68 0.05 0.19% |
About 62% of all STAAR Surgical's investors are looking to take a long position. The analysis of overall sentiment of trading STAAR Surgical stock suggests that some investors are interested at this time. The current market sentiment, together with STAAR Surgical's historical and current headlines, can help investors time the market. In addition, many technical investors use STAAR Surgical stock news signals to limit their universe of possible portfolio assets.
STAAR |
Filed transaction by STAAR Surgical Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at aol.com
STAAR Surgical Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards STAAR Surgical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
STAAR Surgical Fundamental Analysis
We analyze STAAR Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STAAR Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STAAR Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
STAAR Surgical is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
STAAR Surgical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with STAAR Surgical stock to make a market-neutral strategy. Peer analysis of STAAR Surgical could also be used in its relative valuation, which is a method of valuing STAAR Surgical by comparing valuation metrics with similar companies.
Peers
STAAR Surgical Related Equities
MBOT | Microbot Medical | 5.38 | ||||
COO | Cooper Companies, | 0.89 | ||||
NVST | Envista Holdings | 0.65 | ||||
RGEN | Repligen | 0.58 | ||||
MMSI | Merit Medical | 0.29 | ||||
RMD | ResMed | 0.08 | ||||
ATR | AptarGroup | 0.00 | ||||
HOLX | Hologic | 0.00 | ||||
HAE | Haemonetics | 0.00 | ||||
ICUI | ICU Medical | 0.00 | ||||
BDX | Becton Dickinson | 0.64 | ||||
WST | West Pharmaceutical | 0.94 | ||||
ANGO | AngioDynamics | 1.44 |
Complementary Tools for STAAR Stock analysis
When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |